Fabiana Bettoni

Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC

Franciele Hinterholz Knebel, Fabiana Bettoni, Andrea Kazumi Shimada et al. · Lung Cancer · 2017 · 73 citations

Egfr Driver Mutations, Sclerostin, Bone Morphogenic Protein +7

Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients

Camila M. Lopes‐Ramos, Angelita Habr‐Gama, Bruna de Souza Quevedo et al. · BMC Medical Genomics · 2014 · 70 citations · Full text

The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation

Paola A. Carpinetti, Elisa Donnard, Fabiana Bettoni et al. · Oncotarget · 2015 · 67 citations · Full text

Surgical Oncology, Pathology, Liquid Biopsies +18

Intratumoral Genetic Heterogeneity in Rectal Cancer

Fabiana Bettoni, Cibele Masotti, Angelita Habr‐Gama et al. · Annals of Surgery · 2016 · 57 citations

Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer

Camila M. Lopes‐Ramos, Fernanda Christtanini Koyama, Angelita Habr‐Gama et al. · Cancer Genetics · 2015 · 51 citations · Full text

Surgical Oncology, Gene Expression Signatures, Gastrointestinal Oncology +11